Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Athira Pharma discloses new HGFR modulators

May 27, 2022

U.S. researchers present new NR1D2 agonists

May 26, 2022

Antigen-specific immunotolerance platform shows preclinical proof of concept for Parkinson's disease

May 24, 2022

Entrada's EEV treatments progress for Duchenne muscular dystrophy, myotonic dystrophy type 1

May 24, 2022

Novel cofilin inhibitor for the treatment of hemorrhagic brain injury

May 23, 2022

EXG-001-307: a novel gene therapy for spinal muscular atrophy

May 23, 2022

ATH-1019 reduces pain in STZ-induced diabetic neuropathy

May 23, 2022

ORT-247 demonstrates efficacy in preclinical models of CMT and ALS

May 20, 2022

HDAC6 inhibitor CKD-510 shows promise for the treatment of CMT1A

May 20, 2022

Mount Sinai School of Medicine patents ATP6V1A gene expression enhancers

May 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...